Select Page
FDA Approves Thermo Fisher’s CDx Cancer Tissue Test

FDA Approves Thermo Fisher’s CDx Cancer Tissue Test

The U.S. Food and Drug Administration (FDA) has granted premarket approval for Thermo Fisher’s Oncomine Dx Target Test as a companion diagnostic (CDx) developed to help identify non-small cell lung cancer (NSCLC) patients. Lung cancer is the leading cause of...